193 related articles for article (PubMed ID: 35604672)
1. Restoration of Vision and Retinal Responses After Adeno-Associated Virus-Mediated Optogenetic Therapy in Blind Dogs.
Nikonov S; Aravand P; Lyubarsky A; Nikonov R; Luo AJ; Wei Z; Maguire AM; Phelps NT; Shpylchak I; Willett K; Aleman TS; Huckfeldt RM; Ramachandran PS; Bennett J
Transl Vis Sci Technol; 2022 May; 11(5):24. PubMed ID: 35604672
[TBL] [Abstract][Full Text] [Related]
2. Optogenetic Strategies for Vision Restoration.
Lu Q; Pan ZH
Adv Exp Med Biol; 2021; 1293():545-555. PubMed ID: 33398841
[TBL] [Abstract][Full Text] [Related]
3. Degenerated Cones in Cultured Human Retinas Can Successfully Be Optogenetically Reactivated.
Kamar S; Howlett MHC; Klooster J; Graaff W; Csikós T; Rabelink MJWE; Hoeben RC; Kamermans M
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947650
[TBL] [Abstract][Full Text] [Related]
4. Mini-Review: Cell Type-Specific Optogenetic Vision Restoration Approaches.
Chaffiol A; Duebel J
Adv Exp Med Biol; 2018; 1074():69-73. PubMed ID: 29721929
[TBL] [Abstract][Full Text] [Related]
5. Optogenetic Therapy for Visual Restoration.
Sakai D; Tomita H; Maeda A
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499371
[TBL] [Abstract][Full Text] [Related]
6. Optogenetic approaches to therapy for inherited retinal degenerations.
De Silva SR; Moore AT
J Physiol; 2022 Nov; 600(21):4623-4632. PubMed ID: 35908243
[TBL] [Abstract][Full Text] [Related]
7. Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy.
Kralik J; Kleinlogel S
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768944
[TBL] [Abstract][Full Text] [Related]
8. A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina.
Chaffiol A; Caplette R; Jaillard C; Brazhnikova E; Desrosiers M; Dubus E; Duhamel L; Macé E; Marre O; Benoit P; Hantraye P; Bemelmans AP; Bamberg E; Duebel J; Sahel JA; Picaud S; Dalkara D
Mol Ther; 2017 Nov; 25(11):2546-2560. PubMed ID: 28807567
[TBL] [Abstract][Full Text] [Related]
9. Restoration of high-sensitivity and adapting vision with a cone opsin.
Berry MH; Holt A; Salari A; Veit J; Visel M; Levitz J; Aghi K; Gaub BM; Sivyer B; Flannery JG; Isacoff EY
Nat Commun; 2019 Mar; 10(1):1221. PubMed ID: 30874546
[TBL] [Abstract][Full Text] [Related]
10. The functional characteristics of optogenetic gene therapy for vision restoration.
Lindner M; Gilhooley MJ; Peirson SN; Hughes S; Hankins MW
Cell Mol Life Sci; 2021 Feb; 78(4):1597-1613. PubMed ID: 32728765
[TBL] [Abstract][Full Text] [Related]
11. Robust cone-mediated signaling persists late into rod photoreceptor degeneration.
Scalabrino ML; Thapa M; Chew LA; Zhang E; Xu J; Sampath AP; Chen J; Field GD
Elife; 2022 Aug; 11():. PubMed ID: 36040015
[TBL] [Abstract][Full Text] [Related]
12. Advances in Ophthalmic Optogenetics: Approaches and Applications.
Prosseda PP; Tran M; Kowal T; Wang B; Sun Y
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204770
[TBL] [Abstract][Full Text] [Related]
13. Cone-Driven, Geniculocortical Responses in Canine Models of Outer Retinal Disease.
Taskin HO; Wivel J; Aguirre GD; Beltran WA; Aguirre GK
Transl Vis Sci Technol; 2024 Jan; 13(1):18. PubMed ID: 38241039
[TBL] [Abstract][Full Text] [Related]
14. AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa.
Xue Y; Wang SK; Rana P; West ER; Hong CM; Feng H; Wu DM; Cepko CL
Elife; 2021 Apr; 10():. PubMed ID: 33847261
[TBL] [Abstract][Full Text] [Related]
15. Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapy.
De Silva SR; Barnard AR; Hughes S; Tam SKE; Martin C; Singh MS; Barnea-Cramer AO; McClements ME; During MJ; Peirson SN; Hankins MW; MacLaren RE
Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11211-11216. PubMed ID: 28973921
[TBL] [Abstract][Full Text] [Related]
16. Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
Rolling F; Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
Bull Mem Acad R Med Belg; 2006; 161(10-12):497-508; discussion 508-9. PubMed ID: 17503728
[TBL] [Abstract][Full Text] [Related]
17. Optogenetics for visual restoration: From proof of principle to translational challenges.
Lindner M; Gilhooley MJ; Hughes S; Hankins MW
Prog Retin Eye Res; 2022 Nov; 91():101089. PubMed ID: 35691861
[TBL] [Abstract][Full Text] [Related]
18. Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV Restores ON and OFF visual responses in blind mice.
Macé E; Caplette R; Marre O; Sengupta A; Chaffiol A; Barbe P; Desrosiers M; Bamberg E; Sahel JA; Picaud S; Duebel J; Dalkara D
Mol Ther; 2015 Jan; 23(1):7-16. PubMed ID: 25095892
[TBL] [Abstract][Full Text] [Related]
19. AAV-mediated Gene Therapy Halts Retinal Degeneration in PDE6β-deficient Dogs.
Pichard V; Provost N; Mendes-Madeira A; Libeau L; Hulin P; Tshilenge KT; Biget M; Ameline B; Deschamps JY; Weber M; Le Meur G; Colle MA; Moullier P; Rolling F
Mol Ther; 2016 May; 24(5):867-76. PubMed ID: 26857842
[TBL] [Abstract][Full Text] [Related]
20. Optogenetic Stimulation for Restoring Vision to Patients Suffering From Retinal Degenerative Diseases: Current Strategies and Future Directions.
Montazeri L; El Zarif N; Trenholm S; Sawan M
IEEE Trans Biomed Circuits Syst; 2019 Dec; 13(6):1792-1807. PubMed ID: 31689206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
